UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

232 THE SIGNIFICANCE OF TRANSCRIPTION FACTORS FLI1 AND P53 FOR THE EFFECTIVE MEGAKARYOPOIESIS STUDIED IMMUNOHISTOCHEMICALLY IN 5Q- SYNDROME AND THE EFFECT OF LENALIDOMIDE TREATMENT

Leukemia research, 2015-04, Vol.39, p.S116-S116

2015

Volltextzugriff (PDF)

Is the Diagnosis of Patients with Del(5Q) and Trisomy 8 Different, when Found in Unrelated Clones or in One Clone?

Leukemia research, 2017-04, Vol.55, p.S111-S111

2017

Volltextzugriff (PDF)

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

Leukemia research, 2017-04, Vol.55, p.S115-S115

2017

Volltextzugriff (PDF)

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

Leukemia research, 2017-04, Vol.55, p.S132-S132

2017

Volltextzugriff (PDF)

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

Leukemia research, 2017-04, Vol.55, p.S56-S57

2017

Volltextzugriff (PDF)

P-106 Prognostic significance of NPM1, CEBPA, and MLL-PTDs mutations, EVI1, MN1 and ERG expressions in MDS and AML treated with azacitidine

Leukemia research, 2013-05, Vol.37, p.S70-S71

2013

Volltextzugriff (PDF)

106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE

Leukemia research, 2015-04, Vol.39, p.S54-S55

2015

Volltextzugriff (PDF)

42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA

Leukemia research, 2015-04, Vol.39, p.S18-S19

2015

Volltextzugriff (PDF)

170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?

Leukemia research, 2015-04, Vol.39, p.S86-S87

2015

Volltextzugriff (PDF)

TRAIL (Apo2l) suppresses growth of primary human leukemia and myelodysplasia progenitors

Leukemia, 2002, Vol.16 (1), p.67-73

2002

Volltextzugriff (PDF)

P-231 The role of Fli1 and p53 for the effective megakaryopoiesis in 5q-syndrome

Leukemia research, 2013-05, Vol.37, p.S127-S127

2013

Volltextzugriff (PDF)

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

British journal of haematology, 2001-12, Vol.115 (4), p.895-902

2001

Volltextzugriff (PDF)

P064 Erythropoietin and iron overload as opposite regulators of hepcidin expression

Leukemia research, 2009-05, Vol.33, p.S96-S97

2009

Volltextzugriff (PDF)

P055 The decrease of B lymphocytes in MDS – what is the significance of it?

Leukemia research, 2007, Vol.31, p.S70-S70

2007

Volltextzugriff (PDF)

211 Deferasirox vs. deferiprone treatment in iron overloaded patients with myelodysplastic syndrome – a study on 113 patients with low-risk MDS

Leukemia research, 2011, Vol.35, p.S82-S83

2011

Volltextzugriff (PDF)

206 The decrease of B lymphocytes in MDS patients; expression of genes and microRNAs in B cell precursors

Leukemia research, 2011, Vol.35, p.S80-S81

2011

Volltextzugriff (PDF)

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia : final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

Leukemia, 2005-11, Vol.19 (11), p.1929-1933

2005

Volltextzugriff (PDF)

301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)

Leukemia research, 2011, Vol.35, p.S119-S119

2011

Volltextzugriff (PDF)

228 Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathway

Leukemia research, 2011, Vol.35, p.S89-S90

2011

Volltextzugriff (PDF)

247 miRNA expression profiling in 5q- syndrome patients treated with lenalidomide

Leukemia research, 2011, Vol.35, p.S97-S97

2011

Volltextzugriff (PDF)

264 Genomic imbalances in 73 patients with MDS and complex karyotypes

Leukemia research, 2011, Vol.35, p.S104-S104

2011

Volltextzugriff (PDF)

124 Are we warranted to include patients with del 5q and trisomy 8 into the 5q minus syndrome?

Leukemia research, 2011, Vol.35, p.S48-S48

2011

Volltextzugriff (PDF)

274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment

Leukemia research, 2011, Vol.35, p.S108-S108

2011

Volltextzugriff (PDF)

P102 Thrombocytopenia at diagnosis as an important independent negative prognostic marker for low risk MDS patients

Leukemia research, 2007, Vol.31, p.S95-S95

2007

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(163)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(103)
Female
(48)
Male
(48)
Middle Aged
(45)
Aged
(42)
Adult
(36)
Hematology, Oncology And Palliative Medicine
(31)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Aged, 80 And Over
(13)
Biological And Medical Sciences
(12)
Old Medline
(12)
Medical Sciences
(11)
Oncology
(11)
Adolescent
(9)
Hematology
(9)
Acute Disease
(7)
Hematologic And Hematopoietic Diseases
(7)
Animals
(6)
Iron - Metabolism
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

232 THE SIGNIFICANCE OF TRANSCRIPTION FACTORS FLI1 AND P53 FOR THE EFFECTIVE MEGAKARYOPOIESIS STUDIED IMMUNOHISTOCHEMICALLY IN 5Q- SYNDROME AND THE EFFECT OF LENALIDOMIDE TREATMENT

Is the Diagnosis of Patients with Del(5Q) and Trisomy 8 Different, when Found in Unrelated Clones or in One Clone?

High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients

Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition)

MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes (MDS) with Isolated Del(5Q)

P-106 Prognostic significance of NPM1, CEBPA, and MLL-PTDs mutations, EVI1, MN1 and ERG expressions in MDS and AML treated with azacitidine

106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE

42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA

170 MECHANISM OF FORMATION OF COMPLEX CHROMOSOMAL ABERRATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS): CLONAL EVOLUTION OR CHROMOTHRIPSIS?

TRAIL (Apo2l) suppresses growth of primary human leukemia and myelodysplasia progenitors

P-231 The role of Fli1 and p53 for the effective megakaryopoiesis in 5q-syndrome

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC–HOVON randomized phase III study (06914)

P064 Erythropoietin and iron overload as opposite regulators of hepcidin expression

P055 The decrease of B lymphocytes in MDS – what is the significance of it?

211 Deferasirox vs. deferiprone treatment in iron overloaded patients with myelodysplastic syndrome – a study on 113 patients with low-risk MDS

206 The decrease of B lymphocytes in MDS patients; expression of genes and microRNAs in B cell precursors

301 Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and Intermediate-1)

228 Lenalidomide treatment of patients with 5q- syndrome affects genes located in the TNF pathway

247 miRNA expression profiling in 5q- syndrome patients treated with lenalidomide

264 Genomic imbalances in 73 patients with MDS and complex karyotypes

124 Are we warranted to include patients with del 5q and trisomy 8 into the 5q minus syndrome?

274 The response of FLi1, EKLF, TP53 (p53), PU.1, MDM2 gene expression in 5q- syndrome to lenalidomide treatment

P102 Thrombocytopenia at diagnosis as an important independent negative prognostic marker for low risk MDS patients

Suchergebnisse filtern